Education
About Us
Working with TipRanks
Follow Us
Novartis Ag (DE:NOTA)
FRANKFURT:NOTA
Total Valuation
Novartis has a market cap or net worth of $203.62B. The enterprise value is €271.48B.
Market Cap$203.62B
Enterprise Value€271.48B
Share Statistics
Novartis has 2,112,421,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,112,421,900
Owned by Insiders―
Owned by Institutions0.12%
Financial Efficiency
Novartis’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 15.55%.
Return on Equity (ROE)0.27
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)15.55%
Return on Capital Employed (ROCE)0.20
Revenue Per Employee681.60K
Profits Per Employee157.33K
Employee Count75,883
Asset Turnover0.51
Inventory Turnover2.24
Valuation Ratios
The current PE Ratio of Novartis is 16.3. Novartis’s PEG ratio is -0.96.
PE Ratio16.3
PS Ratio3.80
PB Ratio4.46
Price to Fair Value4.46
Price to FCF14.22
Price to Operating Cash Flow11.54
PEG Ratio-0.96
Income Statement
In the last 12 months, Novartis had revenue of 51.72B and earned 11.94B in profits. Earnings per share was 5.92.
Revenue51.72B
Gross Profit38.90B
Operating Income14.54B
Pretax Income13.64B
Net Income11.94B
EBITDA20.71B
Earnings Per Share (EPS)5.92
Cash Flow
In the last 12 months, operating cash flow was 14.50B and capital expenditures -3.18B, giving a free cash flow of 11.32B billion.
Operating Cash Flow14.50B
Free Cash Flow11.32B
Free Cash Flow per Share5.36
Dividends & Yields
Novartis pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.44
52-Week Price Change13.94%
50-Day Moving Average107.86
200-Day Moving Average101.42
Relative Strength Index (RSI)50.45
Average Volume (3m)34.00
Important Dates
Novartis upcoming earnings date is Feb 4, 2026, TBA (Confirmed).
Last Earnings DateOct 28, 2025
Next Earnings DateFeb 4, 2026
Ex-Dividend Date―
Financial Position
Novartis as a current ratio of 1.04, with Debt / Equity ratio of 77.73%
Current Ratio1.04
Quick Ratio0.84
Debt to Market Cap0.15
Net Debt to EBITDA0.96
Interest Coverage Ratio14.03
Taxes
In the past 12 months, Novartis has paid 1.70B in taxes.
Income Tax1.70B
Effective Tax Rate0.12
Enterprise Valuation
Novartis EV to EBITDA ratio is 10.44, with an EV/FCF ratio of 15.66.
EV to Sales4.18
EV to EBITDA10.44
EV to Free Cash Flow15.66
EV to Operating Cash Flow12.27
Balance Sheet
Novartis has $9.75B in cash and marketable securities with $30.12B in debt, giving a net cash position of -$20.36B billion.
Cash & Marketable Securities$9.75B
Total Debt$30.12B
Net Cash-$20.36B
Net Cash Per Share-$9.64
Tangible Book Value Per Share-$3.74
Margins
Gross margin is 76.25%, with operating margin of 28.12%, and net profit margin of 23.09%.
Gross Margin76.25%
Operating Margin28.12%
Pretax Margin26.37%
Net Profit Margin23.09%
EBITDA Margin40.05%
EBIT Margin28.32%
Analyst Forecast
The average price target for Novartis is $103.52, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$103.52
Price Target Upside-5.02% Downside
Analyst ConsensusModerate Sell
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―